Caribou Biosciences Statistics

Total Valuation

CRBU has a market cap or net worth of $168.98 million. The enterprise value is -$116.00 million.

Market Cap	168.98M
Enterprise Value	-116.00M

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, after market close.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

CRBU has 90.36 million shares outstanding. The number of shares has increased by 44.07% in one year.

Shares Outstanding	90.36M
Shares Change (YoY)	+44.07%
Shares Change (QoQ)	+1.16%
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	60.13%
Float	81.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.97
Forward PS	10.72
PB Ratio	0.54
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.75, with a Debt / Equity ratio of 0.09.

Current Ratio	8.75
Quick Ratio	8.55
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.57% and return on invested capital (ROIC) is -27.92%.

Return on Equity (ROE)	-42.57%
Return on Assets (ROA)	-24.49%
Return on Capital (ROIC)	-27.92%
Revenue Per Employee	$209,576
Profits Per Employee	-$781,253
Employee Count	158
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

In the past 12 months, CRBU has paid $193,000 in taxes.

Income Tax	193,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.61% in the last 52 weeks. The beta is 2.27, so CRBU's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	-59.61%
50-Day Moving Average	2.03
200-Day Moving Average	3.82
Relative Strength Index (RSI)	44.67
Average Volume (20 Days)	858,884

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CRBU had revenue of $33.11 million and -$123.44 million in losses. Loss per share was -$1.40.

Revenue	33.11M
Gross Profit	-96.02M
Operating Income	-141.58M
Pretax Income	-123.25M
Net Income	-123.44M
EBITDA	-137.69M
EBIT	-141.58M
Loss Per Share	-$1.40

Full Income Statement

Balance Sheet

The company has $261.65 million in cash and $26.79 million in debt, giving a net cash position of $284.98 million or $3.15 per share.

Cash & Cash Equivalents	261.65M
Total Debt	26.79M
Net Cash	284.98M
Net Cash Per Share	$3.15
Equity (Book Value)	310.46M
Book Value Per Share	3.44
Working Capital	239.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$120.24 million and capital expenditures -$10.72 million, giving a free cash flow of -$130.95 million.

Operating Cash Flow	-120.24M
Capital Expenditures	-10.72M
Free Cash Flow	-130.95M
FCF Per Share	-$1.45

Full Cash Flow Statement

Margins

Gross Margin	-289.97%
Operating Margin	-427.56%
Pretax Margin	-372.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-395.48%

Dividends & Yields

CRBU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.07%
Shareholder Yield	-44.07%
Earnings Yield	-73.05%
FCF Yield	-77.50%

Analyst Forecast

The average price target for CRBU is $14.00, which is 648.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	648.66%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	61.96%
EPS Growth Forecast (5Y)	-11.65%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRBU has an Altman Z-Score of 2.49 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.49
Piotroski F-Score	4